Apellis Pharmaceuticals Inc share price logo

Apellis Pharmaceuticals Inc Share Price

NASDAQ: APLS

Mid Cap

$24.84

-0.56

(-2.20%)

as on

Apellis Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $24.79
    $25.41
    downward going graph

    0.20%

    Downside

    2.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.1
    $38.55
    downward going graph

    35.19%

    Downside

    55.19%

    Upside

    downward going graph

Apellis Pharmaceuticals Inc share price movements today

Previous Close
$25.40
Open
$25.24
Volume
1.1M
Day's Low - High
$24.79 - $25.41
52 Week Low - High
$16.1 - $38.55

Apellis Pharmaceuticals Inc Historical Returns

1 Month Return
-6.51 %
3 Month Return
+ 31.97 %
1 Year Return
-33.94 %
3 Year Return
-61.8 %
5 Year Return
-13.29 %

Apellis Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Apellis Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

-0.3991

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-188.3M

Revenue (TTM)

754.6M

Profit Margin

-30.24%

Return On Equity TTM

906467200.00%

Apellis Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Apellis Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.1B-13.29%NA-30.24%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Apellis Pharmaceuticals Inc Stock including INR - Dollar returns

The Apellis Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Apellis Pharmaceuticals Inc investment value today

Current value as on today

₹71,168

Returns

₹28,832

(-28.83%)

Returns from Apellis Pharmaceuticals Inc Stock

₹33,971 (-33.97%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Apellis Pharmaceuticals Inc Stock

Based on 23 analysts

BUY

82.61%

Buy

17.39%

Hold

0.00%

Sell

Based on 23 analysts, 82.61% of analysts recommend a 'BUY' rating for Apellis Pharmaceuticals Inc. Average target price of $38.56

Apellis Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Apellis Pharmaceuticals Inc.

What analysts predicted

35.58%UPSIDE

Target Price

$38.56

Current Price

$24.84

Analyzed by

23 Analysts

Target

$38.56

Apellis Pharmaceuticals Inc target price $38.56, a slight upside of 35.58% compared to current price of $24.84. According to 23 analysts rating.

Apellis Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Apellis Pharmaceuticals Inc Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-58% versus previous 30 day period

Apellis Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
44
94
110
146
172
199
196
212
166
178
Gross Profit
37
-9
87
126
151
176
163
171
132
164
Operating Income
-175
-120
-148
-84
-62
-29
-47
-26
-83
-33
EBITDA
-169
-114
-132
-79
-58
-27
-43
-24
-80
-30
Interest Expense
7
7
7
7
6
9
12
11
11
11
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-177
-121
-140
-87
-66
-37
-56
-36
-91
-41
Income Tax Expense
0
0
0
1
0
0
0
0
0
0
Net Income
-177
-122
-140
-88
-66
-37
-57
-36
-92
-42
Net Profit Margin
-396.42%
-128.50%
-127.03%
-60.51%
-38.55%
-18.86%
-29.19%
-17.11%
-55.29%
-23.61%

Apellis Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
250
66
75
396
781
Gross Profit
-
-
-50
-127
-288
225
61
69
338
663
Operating Income
-46
-27
-50
-127
-288
-213
-536
-594
-517
-164
EBITDA
6
-27
-50
-125
-298
-312
-731
-617
-495
-154
Interest Expense
-
-
0
2
5
29
13
32
29
40
Depreciation
-
-
0
-
0
0
1
1
1
1
Income Before Tax
-46
-27
-51
-127
-304
-343
-746
-651
-526
-196
Income Tax Expense
-26
-27
0
0
5
1
0
0
2
1
Net Income
-46
-27
-51
-127
-309
-344
-746
-652
-528
-197
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-137.59%
-1121.27%
-864.70%
-133.29%
-25.32%

Apellis Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-122
-140
-88
-66
-37
-57
-36
-92
-42
Operating Cash Flow
-150
-169
-97
-132
-8
34
19
-53
4
Investing Cash Flow
0
0
0
0
0
-
0
0
0
Financing Cash Flow
1
5
-3
108
42
2
-4
0
6
Change in Cash
-149
-163
-101
-25
34
36
14
-52
11

Apellis Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-27
-51
-127
-304
-344
-746
-652
-528
-197
Operating Cash Flow
-26
-46
-131
-211
-160
-563
-513
-594
-87
Investing Cash Flow
-1
-1
-1
-1
-316
247
59
0
0
Financing Cash Flow
14
197
131
388
692
392
365
394
149
Change in Cash
-11
150
0
175
215
74
-88
-200
60

Global Institutional Holdings in Apellis Pharmaceuticals Inc

Funds
Holdings
Wellington Management Company LLP
9.74%
venBio Select Advisor LLC
9.68%
EcoR1 Capital, LLC
9.42%
Vanguard Group Inc
8.02%
Morgan Stanley - Brokerage Accounts
7.62%

Insights on Apellis Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -92.22M → -42.15M (in $), with an average increase of 118.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 166.79M → 178.49M (in $), with an average increase of 6.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 109.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 187.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, APLS stock has moved down by -11.7%

About Apellis Pharmaceuticals Inc

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
OrganisationApellis Pharmaceuticals Inc
Headquarters100 Fifth Avenue, Waltham, MA, United States, 02451
IndustryDistribution Services
CEODr. Cedric Francois M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Apellis Pharmaceuticals Inc

Name

Title

Dr. Pascal Deschatelets Ph.D.

Co-Founder & Chief Scientific Officer

Mr. James G. Chopas CPA

VP, Corporate Controller & Chief Accounting Officer

Ms. Meredith Kaya

Senior Vice President, Investor Relations & Strategic Finance

Prof. Peter Hillmen M.D., Ph.D.

Head of Hematology Engagement & Member of PNH Scientific Advisory Board

Mr. Alec Machiels J.D., MBA

Co-Founder & Director

Mr. Timothy E. Sullivan

CFO & Treasurer

Mr. David O. Watson Esq., J.D.

General Counsel & Secretary

Dr. Cedric Francois M.D., Ph.D.

Co-Founder, President, CEO & Director

Dr. Caroline R. Baumal M.D.

Chief Medical Officer

Ms. Kelley Boucher

Chief People Officer

FAQs

What is Apellis Pharmaceuticals Inc share price today?

Apellis Pharmaceuticals Inc share price today is $24.84 as on at the close of the market. Apellis Pharmaceuticals Inc share today touched a day high of $25.41 and a low of $24.79.

What is the 52 week high and 52 week low for Apellis Pharmaceuticals Inc share?

Apellis Pharmaceuticals Inc share touched a 52 week high of $38.55 on and a 52 week low of $16.1 on . Apellis Pharmaceuticals Inc stock price today i.e. is closed at $24.84,which is 35.56% down from its 52 week high and 54.29% up from its 52 week low.

What is Apellis Pharmaceuticals Inc's market capitalisation today?

Apellis Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Apellis Pharmaceuticals Inc Stock (APLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Apellis Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apellis Pharmaceuticals Inc Shares that will get you 0.0604 shares as per Apellis Pharmaceuticals Inc share price of $24.84 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Apellis Pharmaceuticals Inc Stock (APLS) from India?

Indian investors can start investing in Apellis Pharmaceuticals Inc (APLS) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Apellis Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Apellis Pharmaceuticals Inc share’s latest price of $24.84 as on September 13, 2025 at 1:29 am IST, you will get 0.4026 shares of Apellis Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Apellis Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Apellis Pharmaceuticals Inc stock has given -13.29% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?